Fresenius Kabi now provides the exclusive distribution of the HALO closed system drug-transfer device (CSTD), an airtight CSTD that mechanically prohibits the transfer of environmental contaminants into the system and the escape of drug or vapor concentrations outside the system. The device is designed to minimize individual and environmental exposure to drug vapor, aerosols, and droplets, which are common challenges during the compounding and administration of hazardous drugs like chemotherapy.